1. Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study. Issue 3 (14th March 2022) Authors: Naing, Aung; Powderly, John D; Nemunaitis, John J; Luke, Jason J; Mansfield, Aaron S; Messersmith, Wells A; Sahebjam, Solmaz; LoRusso, Patricia M; Garrido-Laguna, Ignacio; Leopold, Lance; Geschwindt, Ryan; Ding, Kai; Smith, Michael; Berlin, Jordan D Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗